VIPERLAB: EU project aims to boost perovskite solar industry in Europe
VIPERLAB is funded under the European Programme for Research and Innovation Horizon 2020 (Grant No 101006715).
HZB runs state-of-the-art laboratories (here HySPRINT) to advance research on perovskite solar cells. © P. Dera / HZB
Also the EMIL lab at HZB will host VIPERLAB projects. © S. Grunze/HZB
The HZB is coordinating a major European collaborative project to open up new opportunities for the European solar industry. The VIPERLAB project involves 15 renowned research institutions from Europe, as well as Switzerland and Great Britain. It will be funded within the framework of the EU's Horizon 2020 programme for the next three and a half years with a total of 5.5 million euros, from which the HZB will receive just under 840,000 euros.
Perovskite semiconductors enable extremely cheap and powerful solar cells. Many research results on this class of materials are obtained in European laboratories. For example, working groups at Helmholtz-Zentrum Berlin (HZB) have already achieved several world records with perovskite solar cells. Now the HZB is coordinating a major European collaborative project to open up new opportunities for the European solar industry.
VIPERLAB stands for „Fully connected virtual and physical perovskite photovoltaics Lab“. With VIPERLAB, the participating research institutions want to accelerate the development of perovskite PV technology in Europe and promote technology transfer to industry. To this end, they want to establish a close dialogue with the emerging perovskite industry in Europe, both with the help of new initiatives and with more established players such as the European solar industry association Solar Power Europe.
The participating institutions are among the best in European perovskite research. Within VIPERLAB, they will facilitate access to their laboratories and infrastructures so that research teams from public institutions or industry can work with the optimal equipment and methods. A database on materials and building elements will also be established, incorporating information on long-term performance and environmental and economic impacts. This database will enable evidence-based commercial and policy decisions.
Through close collaboration and tailor-made research services, VIPERLAB aims to give European industry a knowledge edge along the entire value chain.
VIPERLAB is funded under the European Programme for Research and Innovation Horizon 2020 (No 101006715).
- Green hydrogen: MXenes shows talent as catalyst for oxygen evolutionThe MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
- SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beerThe first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
- Review on ocular particle therapy (OPT) by international expertsA team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.